跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Wilomax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Wilomax
Approved
STANDARD
Wilomax
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f0f0922c8dca972e
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
f0f0922c8dca972e
Drug Approval Philippines Name
Wilomax
Product Name
Wilomax
Registration Number
DR-XY39115
Brand Name
Wilomax
Generic Name
Amlodipine (as besilate)
Dosage Form
Tablet
Dosage Strength
5 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
Actimed, Inc.
Issuance Date
26 January 2023
Expiry Date
28 February 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f0f0922c8dca972e
Type
Standard
Back to Philippines FDA Approvals